Gregory A. Maglinte, Ph.D. - Publications

Affiliations: 
2009 University of California, Los Angeles, Los Angeles, CA 
Area:
Public Health, Health Care Management, Psychometrics Psychology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Graham CN, Maglinte GA, Schwartzberg LS, Price TJ, Knox HN, Hechmati G, Hjelmgren J, Barber B, Fakih MG. Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-Type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy. Clinical Therapeutics. PMID 27085587 DOI: 10.1016/j.clinthera.2016.03.023  0.4
2015 Velligan DI, Mintz J, Sierra C, Martin ML, Fredrick M, Maglinte GA, Corey-Lisle PK. The Daily Activity Report (DAR) a Novel Measure of Functional Outcome for Serious Mental Illness. Schizophrenia Bulletin. PMID 26712856 DOI: 10.1093/schbul/sbv185  0.4
2015 Wang J, Hechmati G, Dong J, Maglinte GA, Barber B, Douillard JY. Q-TWiST analysis of panitumumab plus FOLFOX4 versus FOLFOX4 alone in patients with previously untreated wild-type RAS metastatic colorectal cancer. Current Medical Research and Opinion. 1-22. PMID 26613286 DOI: 10.1185/03007995.2015.1124075  0.4
2015 Graham CN, Hechmati G, Fakih MG, Knox HN, Maglinte GA, Hjelmgren J, Barber B, Schwartzberg LS. Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer. Journal of Medical Economics. 1-10. PMID 25822327 DOI: 10.3111/13696998.2015.1035659  0.4
2014 Coritsidis GN, Maglinte GA, Acharya A, Saxena A, Chang CL, Hill J, Gitlin M, Lafayette RA. Anemia management trends in hospital-based dialysis centers (HBDCs), 2010 to 2013. Clinical Therapeutics. 36: 408-18. PMID 24582713 DOI: 10.1016/j.clinthera.2014.01.015  0.4
2014 Gaweda AE, Bhat P, Maglinte GA, Chang CL, Hill J, Park GS, Ashfaq A, Gitlin M. TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients. Hemodialysis International. International Symposium On Home Hemodialysis. 18: 38-46. PMID 23968235 DOI: 10.1111/hdi.12078  0.4
2013 Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, Wilcox TK, Kawata AK, Lipton RB. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 53: 644-55. PMID 23458496 DOI: 10.1111/head.12055  0.4
2013 Rendas-Baum R, Bloudek LM, Maglinte GA, Varon SF. The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 22: 1123-33. PMID 22797868 DOI: 10.1007/s11136-012-0230-7  0.4
2012 Maglinte GA, Hays RD, Kaplan RM. US general population norms for telephone administration of the SF-36v2. Journal of Clinical Epidemiology. 65: 497-502. PMID 22269331 DOI: 10.1016/j.jclinepi.2011.09.008  0.4
2012 Bagley CL, Rendas-Baum R, Maglinte GA, Yang M, Varon SF, Lee J, Kosinski M. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache. 52: 409-21. PMID 21929662 DOI: 10.1111/j.1526-4610.2011.01997.x  0.4
Show low-probability matches.